Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)
CNY 18.76
(-0.11%)
CNY 18.76
(-0.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 21.77 Million CNY | -72.64% |
| 2022 | 79.61 Million CNY | 14.07% |
| 2021 | 69.79 Million CNY | 34.4% |
| 2020 | 51.93 Million CNY | 35.54% |
| 2019 | 38.31 Million CNY | -28.55% |
| 2018 | 53.62 Million CNY | 14.38% |
| 2017 | 46.87 Million CNY | 74.02% |
| 2016 | 26.93 Million CNY | 114.55% |
| 2015 | 12.55 Million CNY | 79.14% |
| 2014 | 7 Million CNY | -68.26% |
| 2013 | 22.07 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.87 Million CNY | -67.92% |
| 2024 Q3 | 4 Million CNY | 113.75% |
| 2024 Q1 | 5.83 Million CNY | 738.17% |
| 2023 Q2 | 6.12 Million CNY | -66.1% |
| 2023 Q3 | -1.49 Million CNY | -124.35% |
| 2023 Q4 | -915.08 Thousand CNY | 38.62% |
| 2023 FY | 21.77 Million CNY | -72.64% |
| 2023 Q1 | 18.06 Million CNY | -40.0% |
| 2022 Q2 | 18.57 Million CNY | 25.53% |
| 2022 Q1 | 14.79 Million CNY | -35.36% |
| 2022 FY | 79.61 Million CNY | 14.07% |
| 2022 Q4 | 30.1 Million CNY | 86.62% |
| 2022 Q3 | 16.13 Million CNY | -13.17% |
| 2021 Q1 | 10.86 Million CNY | -39.13% |
| 2021 FY | 69.79 Million CNY | 34.4% |
| 2021 Q3 | 16.12 Million CNY | -18.95% |
| 2021 Q4 | 22.89 Million CNY | 41.95% |
| 2021 Q2 | 19.9 Million CNY | 83.1% |
| 2020 Q2 | 10.03 Million CNY | 18.05% |
| 2020 Q3 | 15.53 Million CNY | 54.83% |
| 2020 Q4 | 17.85 Million CNY | 14.92% |
| 2020 FY | 51.93 Million CNY | 35.54% |
| 2020 Q1 | 8.5 Million CNY | -6.83% |
| 2019 Q2 | 13.8 Million CNY | 139.3% |
| 2019 FY | 38.31 Million CNY | -28.55% |
| 2019 Q4 | 9.12 Million CNY | -5.16% |
| 2019 Q3 | 9.62 Million CNY | -30.29% |
| 2019 Q1 | 5.76 Million CNY | -74.3% |
| 2018 Q4 | 22.44 Million CNY | 97.08% |
| 2018 Q3 | 11.38 Million CNY | 0.0% |
| 2018 FY | 53.62 Million CNY | 14.38% |
| 2017 Q1 | 9.09 Million CNY | 29.31% |
| 2017 Q2 | 9.09 Million CNY | 0.0% |
| 2017 FY | 46.87 Million CNY | 74.02% |
| 2017 Q4 | 12.31 Million CNY | 0.0% |
| 2016 FY | 26.93 Million CNY | 114.55% |
| 2016 Q1 | 5.96 Million CNY | 36.26% |
| 2016 Q2 | 5.96 Million CNY | 0.0% |
| 2016 Q3 | 7.03 Million CNY | 17.98% |
| 2016 Q4 | 7.03 Million CNY | 0.0% |
| 2015 Q4 | 4.37 Million CNY | 0.0% |
| 2015 Q2 | 2.06 Million CNY | 22.48% |
| 2015 FY | 12.55 Million CNY | 79.14% |
| 2015 Q1 | 1.68 Million CNY | -38.28% |
| 2015 Q3 | 4.37 Million CNY | 111.7% |
| 2014 Q2 | 545.41 Thousand CNY | -0.0% |
| 2014 Q1 | 545.41 Thousand CNY | 0.0% |
| 2014 Q3 | 2.73 Million CNY | 401.44% |
| 2014 Q4 | 2.73 Million CNY | 0.0% |
| 2014 FY | 7 Million CNY | -68.26% |
| 2013 FY | 22.07 Million CNY | 0.0% |